A Look at MEK and Autophagy Inhibition
Dr. Conan Kinsey looks at the MEK pathway as way to make immunotherapy more effective for pancreatic cancer patients.
Novel Target Identified that Could Improve Safety of Therapy for Pancreatic Cancer
CAR T cell therapy is an immunotherapy that has shown great promise for the treatment of some blood cancers; however,…
New Standard for Borderline Resectable Pancreatic Cancer
New results suggest that the reference regimen should be neoadjuvant therapy with modified FOLFIRINOX (oxaliplatin 85 mg/m2, irinotecan 180 mg/m2,…
New Computational Tool Reliably Differentiates Between Cancer and Normal Cells From Single-Cell RNA-Sequencing Data
The new tool, dubbed CopyKAT (copy number karyotyping of aneuploid tumors), allows researchers to more easily examine the complex data…
What Will You Do With Your Dash?
G. Paris Johnson is a long-term survivor of pancreatic cancer. She is now focused on advocacy and making the most of her life, what she calls the "dash" between her birth and eventual death.
Step Counts Correlated With QoL With SM-88 in Metastatic Pancreatic Cancer
All patients who enrolled on the trial and received treatment with SM-88 were given wearable devices to passively capture biometric…
No Time to Wait: UK Pancreatic Cancer Patients Struggle with Treatment and Diagnostic Delays
Peter De Rosa of Pancreatic Cancer UK provides an update on how the COVID-19 pandemic has impacted pancreatic cancer patients in the UK.
Ohio State Basic Scientist Researches Role of Key Proteins in Pancreatic Cancer
To date, no biomarker has been identified that is specific enough to detect pancreatic cancer at an early stage and…
Finding More Targets for Pancreatic Cancer Treatment
Dr. Noelle LoConte discusses a clinical trial for cancer patients, including pancreatic cancer patients, that have an NRG1 gene fusion.
New Study to Shed Light on Microbiome’s Relationship to Pancreatic Cancer
The Consortium includes 11 sites across the country that are focusing on several large cohort studies. One of these studies…